CONCEPT_ID	CONCEPT_NAME	CONCEPT_LEVEL	CONCEPT_CLASS	VOCABULARY_ID	CONCEPT_CODE	VALID_START_DATE	VALID_END_DATE	INVALID_REASON	CONCEPT_ID_1	DOMAIN_NAME
40664728	Documentation of diagnosis of chronic kidney disease	1	HCPCS	5	G8771	30-OCT-11	31-DEC-99		40664728	Condition
2617866	Documentation of new diagnosis of initial or recurrent episode of major depressive disorder	1	HCPCS	5	G8467	01-JAN-70	31-DEC-99		2617866	Condition
40659147	Verification and documentation of sudden or rapidly progressive hearing loss	1	HCPCS	5	G8565	01-JAN-70	31-DEC-99		40659147	Condition
40664750	Abdominal aortic aneurysm is not infarenal	1	HCPCS	5	G8821	30-OCT-11	31-DEC-99		40664750	Condition
2617496	Acute myocardial infarction: patient documented to have received aspirin at arrival	1	HCPCS	5	G8006	01-JAN-70	31-DEC-99		2617496	Condition
2617499	Acute myocardial infarction: patient documented to have received beta-blocker at arrival	1	HCPCS	5	G8009	01-JAN-70	31-DEC-99		2617499	Condition
2617497	Acute myocardial infarction: patient not documented to have received aspirin at arrival	1	HCPCS	5	G8007	01-JAN-70	31-DEC-99		2617497	Condition
2617500	Acute myocardial infarction: patient not documented to have received beta-blocker at arrival	1	HCPCS	5	G8010	01-JAN-70	31-DEC-99		2617500	Condition
2617782	Chronic lymphocytic leukemia (cll) patient with no documentation of baseline flow cytometry performed	1	HCPCS	5	G8375	01-JAN-70	31-DEC-99		2617782	Condition
40664869	Clinically node negative (t1n0m0) or t2n0m0) invasive breast cancer	1	HCPCS	5	G8879	30-OCT-11	31-DEC-99		40664869	Condition
2617704	Copd patient not documented to have inhaled bronchodilator therapy prescribed	1	HCPCS	5	G8296	01-JAN-70	31-DEC-99		2617704	Condition
2617701	Copd patient without spirometry results documented	1	HCPCS	5	G8293	01-JAN-70	31-DEC-99		2617701	Condition
2617529	Coronary artery disease - patient with low-density lipoprotein documented to be greater than 100mg/dl	1	HCPCS	5	G8039	01-JAN-70	31-DEC-99		2617529	Condition
2617530	Coronary artery disease - patient with low-density lipoprotein documented to be less than or equal to 100mg/dl	1	HCPCS	5	G8040	01-JAN-70	31-DEC-99		2617530	Condition
2617526	Coronary artery disease patient documented to be on antiplatelet therapy	1	HCPCS	5	G8036	01-JAN-70	31-DEC-99		2617526	Condition
2617527	Coronary artery disease patient not documented to be on antiplatelet therapy	1	HCPCS	5	G8037	01-JAN-70	31-DEC-99		2617527	Condition
40663931	Developed postoperative renal failure or required dialysis	1	HCPCS	5	G8575	01-JAN-70	31-DEC-99		40663931	Condition
2617513	Diabetic patient with most recent blood pressure (within the last 6 months) documented as equal to or greater than 140 systolic or equal to or greater than 80 mmhg diastolic	1	HCPCS	5	G8023	01-JAN-70	31-DEC-99		2617513	Condition
2617514	Diabetic patient with most recent blood pressure (within the last 6 months) documented as less than 140 systolic and less than 80 diastolic	1	HCPCS	5	G8024	01-JAN-70	31-DEC-99		2617514	Condition
2617505	Diabetic patient with most recent hemoglobin a1c level (within the last 6 months) documented as greater than 9%	1	HCPCS	5	G8015	01-JAN-70	31-DEC-99		2617505	Condition
2617506	Diabetic patient with most recent hemoglobin a1c level (within the last 6 months) documented as less than or equal to 9%	1	HCPCS	5	G8016	01-JAN-70	31-DEC-99		2617506	Condition
2617509	Diabetic patient with most recent low-density lipoprotein (within the last 12 months) documented as greater than or equal to 100 mg/dl	1	HCPCS	5	G8019	01-JAN-70	31-DEC-99		2617509	Condition
2617510	Diabetic patient with most recent low-density lipoprotein (within the last 12 months) documented as less than 100 mg/dl	1	HCPCS	5	G8020	01-JAN-70	31-DEC-99		2617510	Condition
2617797	Diabetic patients with no documentation of blood pressure measurement (within the last 12 months)	1	HCPCS	5	G8390	01-JAN-70	31-DEC-99		2617797	Condition
2617792	Diabetic patients with no documentation of hemoglobin a1c level (within the last 12 months)	1	HCPCS	5	G8385	01-JAN-70	31-DEC-99		2617792	Condition
2617793	Diabetic patients with no documentation of low-density lipoprotein (within the last 12 months)	1	HCPCS	5	G8386	01-JAN-70	31-DEC-99		2617793	Condition
2617551	End stage renal disease patient requiring hemodialysis documented to have received vascular access other than autogenous av fistula	1	HCPCS	5	G8082	01-JAN-70	31-DEC-99		2617551	Condition
2617550	End stage renal disease patient requiring hemodialysis vascular access documented to have received autogenous av fistula	1	HCPCS	5	G8081	01-JAN-70	31-DEC-99		2617550	Condition
2617544	End stage renal disease patient with documented dialysis dose of urr greater than or equal to 65% (or kt/v greater than or equal to 1.2)	1	HCPCS	5	G8075	01-JAN-70	31-DEC-99		2617544	Condition
2617545	End stage renal disease patient with documented dialysis dose of urr less than 65% (or kt/v less than 1.2)	1	HCPCS	5	G8076	01-JAN-70	31-DEC-99		2617545	Condition
2617547	End stage renal disease patient with documented hematocrit greater than or equal to 33 (or hemoglobin greater than or equal to 11)	1	HCPCS	5	G8078	01-JAN-70	31-DEC-99		2617547	Condition
2617548	End stage renal disease patient with documented hematocrit less than 33 (or hemoglobin less than 11)	1	HCPCS	5	G8079	01-JAN-70	31-DEC-99		2617548	Condition
2617552	End-stage renal disease patient requiring hemodialysis vascular access was not an eligible candidate for autogenous av fistula	1	HCPCS	5	G8085	01-JAN-70	31-DEC-99		2617552	Condition
2617794	End-stage renal disease patient with a hematocrit or hemoglobin not documented	1	HCPCS	5	G8387	01-JAN-70	31-DEC-99		2617794	Condition
2617795	End-stage renal disease patient with urr or kt/v value not documented, but otherwise eligible for measure	1	HCPCS	5	G8388	01-JAN-70	31-DEC-99		2617795	Condition
2617957	Esrd demo basic bundle level i	1	HCPCS	5	G9013	01-JAN-70	31-DEC-99		2617957	Condition
2617493	Esrd patient for whom less than six dialysis sessions have been provided in a month	1	HCPCS	5	G6	01-JAN-70	31-DEC-99		2617493	Condition
40664645	Female patients with aneurysm minor diameter >6cm	1	HCPCS	5	G8823	30-OCT-11	31-DEC-99		40664645	Condition
40664787	Female patients with aneurysm minor diameter 5.6-6.0 cm	1	HCPCS	5	G8824	30-OCT-11	31-DEC-99		40664787	Condition
2617787	For patients with er or pr positive, stage ic-iii breast cancer, clinician did not document that the patient received or was prescribed tamoxifen or aromatase inhibitor	1	HCPCS	5	G8380	01-JAN-70	31-DEC-99		2617787	Condition
2617788	For patients with er or pr positive, stage ic-iii breast cancer, clinician documented or prescribed that the patient is receiving tamoxifen or aromatase inhibitor	1	HCPCS	5	G8381	01-JAN-70	31-DEC-99		2617788	Condition
2617520	Heart failure patient with left ventricular systolic dysfunction (lvsd) documented to be on beta-blocker therapy	1	HCPCS	5	G8030	01-JAN-70	31-DEC-99		2617520	Condition
2617517	Heart failure patient with left ventricular systolic dysfunction (lvsd) documented to be on either angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker (ace-i or arb) therapy	1	HCPCS	5	G8027	01-JAN-70	31-DEC-99		2617517	Condition
2617521	Heart failure patient with left ventricular systolic dysfunction (lvsd) not documented to be on beta-blocker therapy	1	HCPCS	5	G8031	01-JAN-70	31-DEC-99		2617521	Condition
2617518	Heart failure patient with left ventricular systolic dysfunction (lvsd) not documented to be on either angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker (ace-i or arb) therapy	1	HCPCS	5	G8028	01-JAN-70	31-DEC-99		2617518	Condition
40664135	Infection present	1	HCPCS	5	V8	01-JAN-70	31-DEC-99		40664135	Condition
2617649	Internal carotid stenosis patient in the 30-99% range, and no documentation of reference to measurements of distal internal carotid diameter as the denominator for stenosis measurement	1	HCPCS	5	G8240	01-JAN-70	31-DEC-99		2617649	Condition
40664804	Male patients with aneurysms minor diameter >6 cm	1	HCPCS	5	G8822	30-OCT-11	31-DEC-99		40664804	Condition
40664820	Mild obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of less than 15)	1	HCPCS	5	G8848	30-OCT-11	31-DEC-99		40664820	Condition
2617789	Multiple myeloma patients with no documentation of prescribed or received intravenous bisphosphonate therapy	1	HCPCS	5	G8382	01-JAN-70	31-DEC-99		2617789	Condition
2617796	Myelodysplastic syndrome (mds) patients with no documentation of iron stores prior to receiving erythropoietin therapy	1	HCPCS	5	G8389	01-JAN-70	31-DEC-99		2617796	Condition
2617553	Newly diagnosed chronic obstructive pulmonary disease (copd) patient documented to have received smoking cessation intervention, within 3 months of diagnosis	1	HCPCS	5	G8093	01-JAN-70	31-DEC-99		2617553	Condition
2617554	Newly diagnosed chronic obstructive pulmonary disease (copd) patient not documented to have received smoking cessation intervention, within 3 months of diagnosis	1	HCPCS	5	G8094	01-JAN-70	31-DEC-99		2617554	Condition
2617557	Newly diagnosed osteoporosis patients documented to have been treated with antiresorptive therapy and/or pth within 3 months of diagnosis	1	HCPCS	5	G8103	01-JAN-70	31-DEC-99		2617557	Condition
2618009	Onc dx brst metastic/ recur	1	HCPCS	5	G9075	01-JAN-70	31-DEC-99		2618009	Condition
2618006	Onc dx brst stg1-2 noprogres	1	HCPCS	5	G9072	01-JAN-70	31-DEC-99		2618006	Condition
2618005	Onc dx brst stg1-2B HR,nopro	1	HCPCS	5	G9071	01-JAN-70	31-DEC-99		2618005	Condition
2618007	Onc dx brst stg3-HR, no pro	1	HCPCS	5	G9073	01-JAN-70	31-DEC-99		2618007	Condition
2618008	Onc dx brst stg3-noprogress	1	HCPCS	5	G9074	01-JAN-70	31-DEC-99		2618008	Condition
2618065	Onc dx brst unknown NOS	1	HCPCS	5	G9131	01-JAN-70	31-DEC-99		2618065	Condition
2618021	Onc dx colon metas evid dx	1	HCPCS	5	G9087	01-JAN-70	31-DEC-99		2618021	Condition
2618022	Onc dx colon metas noevid dx	1	HCPCS	5	G9088	01-JAN-70	31-DEC-99		2618022	Condition
2618018	Onc dx colon t1-3,n1-2,no pr	1	HCPCS	5	G9084	01-JAN-70	31-DEC-99		2618018	Condition
2618020	Onc dx colon T1-4 no dx prog	1	HCPCS	5	G9086	01-JAN-70	31-DEC-99		2618020	Condition
2618019	Onc dx colon T4, N0 w/o prog	1	HCPCS	5	G9085	01-JAN-70	31-DEC-99		2618019	Condition
2618030	Onc dx esophag T1-T3 noprog	1	HCPCS	5	G9096	01-JAN-70	31-DEC-99		2618030	Condition
2618031	Onc dx esophageal T4 no prog	1	HCPCS	5	G9097	01-JAN-70	31-DEC-99		2618031	Condition
2618034	Onc dx gastric no recurrence	1	HCPCS	5	G9100	01-JAN-70	31-DEC-99		2618034	Condition
2618035	Onc dx gastric p R1-R2noprog	1	HCPCS	5	G9101	01-JAN-70	31-DEC-99		2618035	Condition
2618046	Onc dx head/neck ext unknown	1	HCPCS	5	G9112	01-JAN-70	31-DEC-99		2618046	Condition
2618045	Onc dx head/neck M1 mets rec	1	HCPCS	5	G9111	01-JAN-70	31-DEC-99		2618045	Condition
2618043	Onc dx head/neck T1-T2no prg	1	HCPCS	5	G9109	01-JAN-70	31-DEC-99		2618043	Condition
2618044	Onc dx head/neck T3-4 noprog	1	HCPCS	5	G9110	01-JAN-70	31-DEC-99		2618044	Condition
2617998	Onc dx nsclc stg2 no dx prog	1	HCPCS	5	G9064	01-JAN-70	31-DEC-99		2617998	Condition
2617999	Onc dx nsclc stg3A no progre	1	HCPCS	5	G9065	01-JAN-70	31-DEC-99		2617999	Condition
2617997	Onc dx nsclc stgI no dx prog	1	HCPCS	5	G9063	01-JAN-70	31-DEC-99		2617997	Condition
2618002	Onc dx nsclc/sclc limited	1	HCPCS	5	G9068	01-JAN-70	31-DEC-99		2618002	Condition
2618048	Onc dx ovarian stg1A-B or 2	1	HCPCS	5	G9114	01-JAN-70	31-DEC-99		2618048	Condition
2618011	Onc dx prostate T1no progres	1	HCPCS	5	G9077	01-JAN-70	31-DEC-99		2618011	Condition
2618024	Onc dx rectal T1-2 no progr	1	HCPCS	5	G9090	01-JAN-70	31-DEC-99		2618024	Condition
2618026	Onc dx rectal T1-3,N1-2noprg	1	HCPCS	5	G9092	01-JAN-70	31-DEC-99		2618026	Condition
2618025	Onc dx rectal T3 N0 no prog	1	HCPCS	5	G9091	01-JAN-70	31-DEC-99		2618025	Condition
2618027	Onc dx rectal T4,N,M0 no prg	1	HCPCS	5	G9093	01-JAN-70	31-DEC-99		2618027	Condition
2617987	Onc expectant management pt	1	HCPCS	5	G9053	01-JAN-70	31-DEC-99		2617987	Condition
2617993	Onc prac mgmt pt opt alterna	1	HCPCS	5	G9059	01-JAN-70	31-DEC-99		2617993	Condition
2618058	Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; accelerated phase not in hematologic cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9124	01-JAN-70	31-DEC-99		2618058	Condition
2618059	Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; blast phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9125	01-JAN-70	31-DEC-99		2618059	Condition
2618057	Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; chronic phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9123	01-JAN-70	31-DEC-99		2618057	Condition
2618073	Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown, staging in progress, not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9139	01-JAN-70	31-DEC-99		2618073	Condition
2618060	Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9126	01-JAN-70	31-DEC-99		2618060	Condition
2618023	Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9089	01-JAN-70	31-DEC-99		2618023	Condition
2618033	Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9099	01-JAN-70	31-DEC-99		2618033	Condition
2618032	Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9098	01-JAN-70	31-DEC-99		2618032	Condition
2618036	Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m0, unresectable with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9102	01-JAN-70	31-DEC-99		2618036	Condition
2618037	Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9103	01-JAN-70	31-DEC-99		2618037	Condition
2618038	Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9104	01-JAN-70	31-DEC-99		2618038	Condition
2618064	Oncology; disease status; limited to multiple myeloma, systemic disease; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9130	01-JAN-70	31-DEC-99		2618064	Condition
2618062	Oncology; disease status; limited to multiple myeloma, systemic disease; smoldering, stage i (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9128	01-JAN-70	31-DEC-99		2618062	Condition
2618063	Oncology; disease status; limited to multiple myeloma, systemic disease; stage ii or higher (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9129	01-JAN-70	31-DEC-99		2618063	Condition
2618001	Oncology; disease status; limited to non-small cell lung cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9067	01-JAN-70	31-DEC-99		2618001	Condition
2618000	Oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9066	01-JAN-70	31-DEC-99		2618000	Condition
2618072	Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; diagnostic evaluation, stage not determined, evaluation of possible relapse or non-response to therapy, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9138	01-JAN-70	31-DEC-99		2618072	Condition
2618071	Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9137	01-JAN-70	31-DEC-99		2618071	Condition
2618068	Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage i, ii at diagnosis, not relapsed, not refractory (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9134	01-JAN-70	31-DEC-99		2618068	Condition
2618069	Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9135	01-JAN-70	31-DEC-99		2618069	Condition
2618070	Oncology; disease status; non-hodgkin's lymphoma, transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9136	01-JAN-70	31-DEC-99		2618070	Condition
2618050	Oncology; disease status; ovarian cancer, limited to epithelial cancer; evidence of disease progression, or recurrence, and/or platinum resistance (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9116	01-JAN-70	31-DEC-99		2618050	Condition
2618051	Oncology; disease status; ovarian cancer, limited to epithelial cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration  project)	1	HCPCS	5	G9117	01-JAN-70	31-DEC-99		2618051	Condition
2618047	Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 1) without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9113	01-JAN-70	31-DEC-99		2618047	Condition
2618049	Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression, recurrence, or metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9115	01-JAN-70	31-DEC-99		2618049	Condition
2618039	Oncology; disease status; pancreatic cancer, limited to adenocarcinoma as predominant cell type; post r0 resection without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9105	01-JAN-70	31-DEC-99		2618039	Condition
2618042	Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9108	01-JAN-70	31-DEC-99		2618042	Condition
2618040	Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; post r1 or r2 resection with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9106	01-JAN-70	31-DEC-99		2618040	Condition
2618041	Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; unresectable at diagnosis, m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9107	01-JAN-70	31-DEC-99		2618041	Condition
2618012	ONCOLOGY; DISEASE STATUS; PROSTATE CANCER, LIMITED TO ADENOCARCINOMA AS PREDOMINANT CELL TYPE; T2 OR T3A GLEASON 8-10 OR PSA > 20 AT DIAGNOSIS WITH NO EVIDENCE OF DISEASE PROGRESSION, RECURRENCE, OR METASTASES	1	HCPCS	5	G9078	01-JAN-70	31-DEC-99		2618012	Condition
2618013	Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t3b-t4, any n; any t, n1 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9079	01-JAN-70	31-DEC-99		2618013	Condition
2618014	Oncology; disease status; prostate cancer, limited to adenocarcinoma; after initial treatment with rising psa or failure of psa decline (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9080	01-JAN-70	31-DEC-99		2618014	Condition
2618017	Oncology; disease status; prostate cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9083	01-JAN-70	31-DEC-99		2618017	Condition
2618066	Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9132	01-JAN-70	31-DEC-99		2618066	Condition
2618067	Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9133	01-JAN-70	31-DEC-99		2618067	Condition
2618029	Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9095	01-JAN-70	31-DEC-99		2618029	Condition
2618028	Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9094	01-JAN-70	31-DEC-99		2618028	Condition
2618003	Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small cell; extensive stage at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9069	01-JAN-70	31-DEC-99		2618003	Condition
2618004	Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9070	01-JAN-70	31-DEC-99		2618004	Condition
43533178	One or more neuropsychiatric symptoms	1	HCPCS	5	G8947	28-AUG-13	31-DEC-99		43533178	Condition
2617597	Patient with heart failure and atrial fibrillation documented to be on warfarin therapy	1	HCPCS	5	G8183	01-JAN-70	31-DEC-99		2617597	Condition
2617599	Patients diagnosed with symptomatic osteoarthritis with documented annual assessment of function and pain	1	HCPCS	5	G8185	01-JAN-70	31-DEC-99		2617599	Condition
2617798	Patients with persistent asthma, no documentation of preferred long term control medication or acceptable alternative treatment prescribed	1	HCPCS	5	G8391	01-JAN-70	31-DEC-99		2617798	Condition
2617502	Pneumonia: patient documented to have received antibiotic within 4 hours of presentation	1	HCPCS	5	G8012	01-JAN-70	31-DEC-99		2617502	Condition
2617503	Pneumonia: patient not documented to have received antibiotic within 4 hours of presentation	1	HCPCS	5	G8013	01-JAN-70	31-DEC-99		2617503	Condition
2617494	Pregnancy resulted from rape or incest or pregnancy certified by physician as life threatening	1	HCPCS	5	G7	01-JAN-70	31-DEC-99		2617494	Condition
2617714	Primary open-angle glaucoma patient with intraocular pressure above the target range goal documented to have received plan of care	1	HCPCS	5	G8306	01-JAN-70	31-DEC-99		2617714	Condition
2617716	Primary open-angle glaucoma patient with intraocular pressure above the target range goal, and not documented to have received plan of care during the reporting year	1	HCPCS	5	G8308	01-JAN-70	31-DEC-99		2617716	Condition
40664750	Abdominal aortic aneurysm is not infarenal	1	HCPCS	5	G8821	30-OCT-11	31-DEC-99		40664750	Condition
2617496	Acute myocardial infarction: patient documented to have received aspirin at arrival	1	HCPCS	5	G8006	01-JAN-70	31-DEC-99		2617496	Condition
2617499	Acute myocardial infarction: patient documented to have received beta-blocker at arrival	1	HCPCS	5	G8009	01-JAN-70	31-DEC-99		2617499	Condition
2617497	Acute myocardial infarction: patient not documented to have received aspirin at arrival	1	HCPCS	5	G8007	01-JAN-70	31-DEC-99		2617497	Condition
2617500	Acute myocardial infarction: patient not documented to have received beta-blocker at arrival	1	HCPCS	5	G8010	01-JAN-70	31-DEC-99		2617500	Condition
2617782	Chronic lymphocytic leukemia (cll) patient with no documentation of baseline flow cytometry performed	1	HCPCS	5	G8375	01-JAN-70	31-DEC-99		2617782	Condition
40664869	Clinically node negative (t1n0m0) or t2n0m0) invasive breast cancer	1	HCPCS	5	G8879	30-OCT-11	31-DEC-99		40664869	Condition
2617704	Copd patient not documented to have inhaled bronchodilator therapy prescribed	1	HCPCS	5	G8296	01-JAN-70	31-DEC-99		2617704	Condition
2617701	Copd patient without spirometry results documented	1	HCPCS	5	G8293	01-JAN-70	31-DEC-99		2617701	Condition
2617529	Coronary artery disease - patient with low-density lipoprotein documented to be greater than 100mg/dl	1	HCPCS	5	G8039	01-JAN-70	31-DEC-99		2617529	Condition
2617530	Coronary artery disease - patient with low-density lipoprotein documented to be less than or equal to 100mg/dl	1	HCPCS	5	G8040	01-JAN-70	31-DEC-99		2617530	Condition
2617526	Coronary artery disease patient documented to be on antiplatelet therapy	1	HCPCS	5	G8036	01-JAN-70	31-DEC-99		2617526	Condition
2617527	Coronary artery disease patient not documented to be on antiplatelet therapy	1	HCPCS	5	G8037	01-JAN-70	31-DEC-99		2617527	Condition
40663931	Developed postoperative renal failure or required dialysis	1	HCPCS	5	G8575	01-JAN-70	31-DEC-99		40663931	Condition
2617513	Diabetic patient with most recent blood pressure (within the last 6 months) documented as equal to or greater than 140 systolic or equal to or greater than 80 mmhg diastolic	1	HCPCS	5	G8023	01-JAN-70	31-DEC-99		2617513	Condition
2617514	Diabetic patient with most recent blood pressure (within the last 6 months) documented as less than 140 systolic and less than 80 diastolic	1	HCPCS	5	G8024	01-JAN-70	31-DEC-99		2617514	Condition
2617505	Diabetic patient with most recent hemoglobin a1c level (within the last 6 months) documented as greater than 9%	1	HCPCS	5	G8015	01-JAN-70	31-DEC-99		2617505	Condition
2617506	Diabetic patient with most recent hemoglobin a1c level (within the last 6 months) documented as less than or equal to 9%	1	HCPCS	5	G8016	01-JAN-70	31-DEC-99		2617506	Condition
2617509	Diabetic patient with most recent low-density lipoprotein (within the last 12 months) documented as greater than or equal to 100 mg/dl	1	HCPCS	5	G8019	01-JAN-70	31-DEC-99		2617509	Condition
2617510	Diabetic patient with most recent low-density lipoprotein (within the last 12 months) documented as less than 100 mg/dl	1	HCPCS	5	G8020	01-JAN-70	31-DEC-99		2617510	Condition
2617797	Diabetic patients with no documentation of blood pressure measurement (within the last 12 months)	1	HCPCS	5	G8390	01-JAN-70	31-DEC-99		2617797	Condition
2617792	Diabetic patients with no documentation of hemoglobin a1c level (within the last 12 months)	1	HCPCS	5	G8385	01-JAN-70	31-DEC-99		2617792	Condition
2617793	Diabetic patients with no documentation of low-density lipoprotein (within the last 12 months)	1	HCPCS	5	G8386	01-JAN-70	31-DEC-99		2617793	Condition
2617551	End stage renal disease patient requiring hemodialysis documented to have received vascular access other than autogenous av fistula	1	HCPCS	5	G8082	01-JAN-70	31-DEC-99		2617551	Condition
2617550	End stage renal disease patient requiring hemodialysis vascular access documented to have received autogenous av fistula	1	HCPCS	5	G8081	01-JAN-70	31-DEC-99		2617550	Condition
2617544	End stage renal disease patient with documented dialysis dose of urr greater than or equal to 65% (or kt/v greater than or equal to 1.2)	1	HCPCS	5	G8075	01-JAN-70	31-DEC-99		2617544	Condition
2617545	End stage renal disease patient with documented dialysis dose of urr less than 65% (or kt/v less than 1.2)	1	HCPCS	5	G8076	01-JAN-70	31-DEC-99		2617545	Condition
2617547	End stage renal disease patient with documented hematocrit greater than or equal to 33 (or hemoglobin greater than or equal to 11)	1	HCPCS	5	G8078	01-JAN-70	31-DEC-99		2617547	Condition
2617548	End stage renal disease patient with documented hematocrit less than 33 (or hemoglobin less than 11)	1	HCPCS	5	G8079	01-JAN-70	31-DEC-99		2617548	Condition
2617552	End-stage renal disease patient requiring hemodialysis vascular access was not an eligible candidate for autogenous av fistula	1	HCPCS	5	G8085	01-JAN-70	31-DEC-99		2617552	Condition
2617794	End-stage renal disease patient with a hematocrit or hemoglobin not documented	1	HCPCS	5	G8387	01-JAN-70	31-DEC-99		2617794	Condition
2617795	End-stage renal disease patient with urr or kt/v value not documented, but otherwise eligible for measure	1	HCPCS	5	G8388	01-JAN-70	31-DEC-99		2617795	Condition
2617957	Esrd demo basic bundle level i	1	HCPCS	5	G9013	01-JAN-70	31-DEC-99		2617957	Condition
2617493	Esrd patient for whom less than six dialysis sessions have been provided in a month	1	HCPCS	5	G6	01-JAN-70	31-DEC-99		2617493	Condition
40664645	Female patients with aneurysm minor diameter >6cm	1	HCPCS	5	G8823	30-OCT-11	31-DEC-99		40664645	Condition
40664787	Female patients with aneurysm minor diameter 5.6-6.0 cm	1	HCPCS	5	G8824	30-OCT-11	31-DEC-99		40664787	Condition
2617787	For patients with er or pr positive, stage ic-iii breast cancer, clinician did not document that the patient received or was prescribed tamoxifen or aromatase inhibitor	1	HCPCS	5	G8380	01-JAN-70	31-DEC-99		2617787	Condition
2617788	For patients with er or pr positive, stage ic-iii breast cancer, clinician documented or prescribed that the patient is receiving tamoxifen or aromatase inhibitor	1	HCPCS	5	G8381	01-JAN-70	31-DEC-99		2617788	Condition
2617520	Heart failure patient with left ventricular systolic dysfunction (lvsd) documented to be on beta-blocker therapy	1	HCPCS	5	G8030	01-JAN-70	31-DEC-99		2617520	Condition
2617517	Heart failure patient with left ventricular systolic dysfunction (lvsd) documented to be on either angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker (ace-i or arb) therapy	1	HCPCS	5	G8027	01-JAN-70	31-DEC-99		2617517	Condition
2617521	Heart failure patient with left ventricular systolic dysfunction (lvsd) not documented to be on beta-blocker therapy	1	HCPCS	5	G8031	01-JAN-70	31-DEC-99		2617521	Condition
2617518	Heart failure patient with left ventricular systolic dysfunction (lvsd) not documented to be on either angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker (ace-i or arb) therapy	1	HCPCS	5	G8028	01-JAN-70	31-DEC-99		2617518	Condition
40664135	Infection present	1	HCPCS	5	V8	01-JAN-70	31-DEC-99		40664135	Condition
2617649	Internal carotid stenosis patient in the 30-99% range, and no documentation of reference to measurements of distal internal carotid diameter as the denominator for stenosis measurement	1	HCPCS	5	G8240	01-JAN-70	31-DEC-99		2617649	Condition
40664804	Male patients with aneurysms minor diameter >6 cm	1	HCPCS	5	G8822	30-OCT-11	31-DEC-99		40664804	Condition
40664820	Mild obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of less than 15)	1	HCPCS	5	G8848	30-OCT-11	31-DEC-99		40664820	Condition
2617789	Multiple myeloma patients with no documentation of prescribed or received intravenous bisphosphonate therapy	1	HCPCS	5	G8382	01-JAN-70	31-DEC-99		2617789	Condition
2617796	Myelodysplastic syndrome (mds) patients with no documentation of iron stores prior to receiving erythropoietin therapy	1	HCPCS	5	G8389	01-JAN-70	31-DEC-99		2617796	Condition
2617553	Newly diagnosed chronic obstructive pulmonary disease (copd) patient documented to have received smoking cessation intervention, within 3 months of diagnosis	1	HCPCS	5	G8093	01-JAN-70	31-DEC-99		2617553	Condition
2617554	Newly diagnosed chronic obstructive pulmonary disease (copd) patient not documented to have received smoking cessation intervention, within 3 months of diagnosis	1	HCPCS	5	G8094	01-JAN-70	31-DEC-99		2617554	Condition
2617557	Newly diagnosed osteoporosis patients documented to have been treated with antiresorptive therapy and/or pth within 3 months of diagnosis	1	HCPCS	5	G8103	01-JAN-70	31-DEC-99		2617557	Condition
2618009	Onc dx brst metastic/ recur	1	HCPCS	5	G9075	01-JAN-70	31-DEC-99		2618009	Condition
2618006	Onc dx brst stg1-2 noprogres	1	HCPCS	5	G9072	01-JAN-70	31-DEC-99		2618006	Condition
2618005	Onc dx brst stg1-2B HR,nopro	1	HCPCS	5	G9071	01-JAN-70	31-DEC-99		2618005	Condition
2618007	Onc dx brst stg3-HR, no pro	1	HCPCS	5	G9073	01-JAN-70	31-DEC-99		2618007	Condition
2618008	Onc dx brst stg3-noprogress	1	HCPCS	5	G9074	01-JAN-70	31-DEC-99		2618008	Condition
2618065	Onc dx brst unknown NOS	1	HCPCS	5	G9131	01-JAN-70	31-DEC-99		2618065	Condition
2618021	Onc dx colon metas evid dx	1	HCPCS	5	G9087	01-JAN-70	31-DEC-99		2618021	Condition
2618022	Onc dx colon metas noevid dx	1	HCPCS	5	G9088	01-JAN-70	31-DEC-99		2618022	Condition
2618018	Onc dx colon t1-3,n1-2,no pr	1	HCPCS	5	G9084	01-JAN-70	31-DEC-99		2618018	Condition
2618020	Onc dx colon T1-4 no dx prog	1	HCPCS	5	G9086	01-JAN-70	31-DEC-99		2618020	Condition
2618019	Onc dx colon T4, N0 w/o prog	1	HCPCS	5	G9085	01-JAN-70	31-DEC-99		2618019	Condition
2618030	Onc dx esophag T1-T3 noprog	1	HCPCS	5	G9096	01-JAN-70	31-DEC-99		2618030	Condition
2618031	Onc dx esophageal T4 no prog	1	HCPCS	5	G9097	01-JAN-70	31-DEC-99		2618031	Condition
2618034	Onc dx gastric no recurrence	1	HCPCS	5	G9100	01-JAN-70	31-DEC-99		2618034	Condition
2618035	Onc dx gastric p R1-R2noprog	1	HCPCS	5	G9101	01-JAN-70	31-DEC-99		2618035	Condition
2618046	Onc dx head/neck ext unknown	1	HCPCS	5	G9112	01-JAN-70	31-DEC-99		2618046	Condition
2618045	Onc dx head/neck M1 mets rec	1	HCPCS	5	G9111	01-JAN-70	31-DEC-99		2618045	Condition
2618043	Onc dx head/neck T1-T2no prg	1	HCPCS	5	G9109	01-JAN-70	31-DEC-99		2618043	Condition
2618044	Onc dx head/neck T3-4 noprog	1	HCPCS	5	G9110	01-JAN-70	31-DEC-99		2618044	Condition
2617998	Onc dx nsclc stg2 no dx prog	1	HCPCS	5	G9064	01-JAN-70	31-DEC-99		2617998	Condition
2617999	Onc dx nsclc stg3A no progre	1	HCPCS	5	G9065	01-JAN-70	31-DEC-99		2617999	Condition
2617997	Onc dx nsclc stgI no dx prog	1	HCPCS	5	G9063	01-JAN-70	31-DEC-99		2617997	Condition
2618002	Onc dx nsclc/sclc limited	1	HCPCS	5	G9068	01-JAN-70	31-DEC-99		2618002	Condition
2618048	Onc dx ovarian stg1A-B or 2	1	HCPCS	5	G9114	01-JAN-70	31-DEC-99		2618048	Condition
2618011	Onc dx prostate T1no progres	1	HCPCS	5	G9077	01-JAN-70	31-DEC-99		2618011	Condition
2618024	Onc dx rectal T1-2 no progr	1	HCPCS	5	G9090	01-JAN-70	31-DEC-99		2618024	Condition
2618026	Onc dx rectal T1-3,N1-2noprg	1	HCPCS	5	G9092	01-JAN-70	31-DEC-99		2618026	Condition
2618025	Onc dx rectal T3 N0 no prog	1	HCPCS	5	G9091	01-JAN-70	31-DEC-99		2618025	Condition
2618027	Onc dx rectal T4,N,M0 no prg	1	HCPCS	5	G9093	01-JAN-70	31-DEC-99		2618027	Condition
2617987	Onc expectant management pt	1	HCPCS	5	G9053	01-JAN-70	31-DEC-99		2617987	Condition
2617993	Onc prac mgmt pt opt alterna	1	HCPCS	5	G9059	01-JAN-70	31-DEC-99		2617993	Condition
2618058	Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; accelerated phase not in hematologic cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9124	01-JAN-70	31-DEC-99		2618058	Condition
2618059	Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; blast phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9125	01-JAN-70	31-DEC-99		2618059	Condition
2618057	Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; chronic phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9123	01-JAN-70	31-DEC-99		2618057	Condition
2618073	Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown, staging in progress, not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9139	01-JAN-70	31-DEC-99		2618073	Condition
2618060	Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9126	01-JAN-70	31-DEC-99		2618060	Condition
2618023	Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9089	01-JAN-70	31-DEC-99		2618023	Condition
2618033	Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9099	01-JAN-70	31-DEC-99		2618033	Condition
2618032	Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9098	01-JAN-70	31-DEC-99		2618032	Condition
2618036	Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m0, unresectable with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9102	01-JAN-70	31-DEC-99		2618036	Condition
2618037	Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9103	01-JAN-70	31-DEC-99		2618037	Condition
2618038	Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9104	01-JAN-70	31-DEC-99		2618038	Condition
2618064	Oncology; disease status; limited to multiple myeloma, systemic disease; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9130	01-JAN-70	31-DEC-99		2618064	Condition
2618062	Oncology; disease status; limited to multiple myeloma, systemic disease; smoldering, stage i (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9128	01-JAN-70	31-DEC-99		2618062	Condition
2618063	Oncology; disease status; limited to multiple myeloma, systemic disease; stage ii or higher (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9129	01-JAN-70	31-DEC-99		2618063	Condition
2618001	Oncology; disease status; limited to non-small cell lung cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9067	01-JAN-70	31-DEC-99		2618001	Condition
2618000	Oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9066	01-JAN-70	31-DEC-99		2618000	Condition
2618072	Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; diagnostic evaluation, stage not determined, evaluation of possible relapse or non-response to therapy, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9138	01-JAN-70	31-DEC-99		2618072	Condition
2618071	Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9137	01-JAN-70	31-DEC-99		2618071	Condition
2618068	Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage i, ii at diagnosis, not relapsed, not refractory (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9134	01-JAN-70	31-DEC-99		2618068	Condition
2618069	Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9135	01-JAN-70	31-DEC-99		2618069	Condition
2618070	Oncology; disease status; non-hodgkin's lymphoma, transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9136	01-JAN-70	31-DEC-99		2618070	Condition
2618050	Oncology; disease status; ovarian cancer, limited to epithelial cancer; evidence of disease progression, or recurrence, and/or platinum resistance (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9116	01-JAN-70	31-DEC-99		2618050	Condition
2618051	Oncology; disease status; ovarian cancer, limited to epithelial cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration  project)	1	HCPCS	5	G9117	01-JAN-70	31-DEC-99		2618051	Condition
2618047	Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 1) without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9113	01-JAN-70	31-DEC-99		2618047	Condition
2618049	Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression, recurrence, or metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9115	01-JAN-70	31-DEC-99		2618049	Condition
2618039	Oncology; disease status; pancreatic cancer, limited to adenocarcinoma as predominant cell type; post r0 resection without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9105	01-JAN-70	31-DEC-99		2618039	Condition
2618042	Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9108	01-JAN-70	31-DEC-99		2618042	Condition
2618040	Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; post r1 or r2 resection with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9106	01-JAN-70	31-DEC-99		2618040	Condition
2618041	Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; unresectable at diagnosis, m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9107	01-JAN-70	31-DEC-99		2618041	Condition
2618012	ONCOLOGY; DISEASE STATUS; PROSTATE CANCER, LIMITED TO ADENOCARCINOMA AS PREDOMINANT CELL TYPE; T2 OR T3A GLEASON 8-10 OR PSA > 20 AT DIAGNOSIS WITH NO EVIDENCE OF DISEASE PROGRESSION, RECURRENCE, OR METASTASES	1	HCPCS	5	G9078	01-JAN-70	31-DEC-99		2618012	Condition
2618013	Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t3b-t4, any n; any t, n1 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9079	01-JAN-70	31-DEC-99		2618013	Condition
2618014	Oncology; disease status; prostate cancer, limited to adenocarcinoma; after initial treatment with rising psa or failure of psa decline (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9080	01-JAN-70	31-DEC-99		2618014	Condition
2618017	Oncology; disease status; prostate cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9083	01-JAN-70	31-DEC-99		2618017	Condition
2618066	Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9132	01-JAN-70	31-DEC-99		2618066	Condition
2618067	Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9133	01-JAN-70	31-DEC-99		2618067	Condition
2618029	Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9095	01-JAN-70	31-DEC-99		2618029	Condition
2618028	Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9094	01-JAN-70	31-DEC-99		2618028	Condition
2618003	Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small cell; extensive stage at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9069	01-JAN-70	31-DEC-99		2618003	Condition
2618004	Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)	1	HCPCS	5	G9070	01-JAN-70	31-DEC-99		2618004	Condition
43533178	One or more neuropsychiatric symptoms	1	HCPCS	5	G8947	28-AUG-13	31-DEC-99		43533178	Condition
2617597	Patient with heart failure and atrial fibrillation documented to be on warfarin therapy	1	HCPCS	5	G8183	01-JAN-70	31-DEC-99		2617597	Condition
2617599	Patients diagnosed with symptomatic osteoarthritis with documented annual assessment of function and pain	1	HCPCS	5	G8185	01-JAN-70	31-DEC-99		2617599	Condition
2617798	Patients with persistent asthma, no documentation of preferred long term control medication or acceptable alternative treatment prescribed	1	HCPCS	5	G8391	01-JAN-70	31-DEC-99		2617798	Condition
2617502	Pneumonia: patient documented to have received antibiotic within 4 hours of presentation	1	HCPCS	5	G8012	01-JAN-70	31-DEC-99		2617502	Condition
2617503	Pneumonia: patient not documented to have received antibiotic within 4 hours of presentation	1	HCPCS	5	G8013	01-JAN-70	31-DEC-99		2617503	Condition
2617494	Pregnancy resulted from rape or incest or pregnancy certified by physician as life threatening	1	HCPCS	5	G7	01-JAN-70	31-DEC-99		2617494	Condition
2617714	Primary open-angle glaucoma patient with intraocular pressure above the target range goal documented to have received plan of care	1	HCPCS	5	G8306	01-JAN-70	31-DEC-99		2617714	Condition
2617716	Primary open-angle glaucoma patient with intraocular pressure above the target range goal, and not documented to have received plan of care during the reporting year	1	HCPCS	5	G8308	01-JAN-70	31-DEC-99		2617716	Condition
40664658	Moderate or severe obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of 15 or greater)	1	HCPCS	5	G8846	30-OCT-11	31-DEC-99		40664658	Condition
2720881	Patient pronounced dead after ambulance called	1	HCPCS	5	QL	01-JAN-70	31-DEC-99		2720881	Condition
